These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8031338)

  • 1. Therapeutic conservatism.
    Griffin JP
    J R Coll Physicians Lond; 1993 Jul; 27(3):339. PubMed ID: 8031338
    [No Abstract]   [Full Text] [Related]  

  • 2. Curbing the drugs bill.
    Dean M
    Lancet; 1992 Dec 19-26; 340(8834-8835):1531-2. PubMed ID: 1361610
    [No Abstract]   [Full Text] [Related]  

  • 3. Increasing cost of medicines.
    Griffin JP
    Lancet; 1993 May; 341(8853):1156-7. PubMed ID: 8097843
    [No Abstract]   [Full Text] [Related]  

  • 4. Value based pricing for NHS drugs: an opportunity not to be missed?
    Claxton K; Briggs A; Buxton MJ; Culyer AJ; McCabe C; Walker S; Sculpher MJ
    BMJ; 2008 Feb; 336(7638):251-4. PubMed ID: 18244997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Government pushes ahead with plan for cheaper drugs deal for NHS.
    Timmins N
    BMJ; 2007 Aug; 335(7614):273. PubMed ID: 17690350
    [No Abstract]   [Full Text] [Related]  

  • 6. Should NICE's threshold range for cost per QALY be raised? No.
    Raftery J
    BMJ; 2009 Jan; 338():b185. PubMed ID: 19171562
    [No Abstract]   [Full Text] [Related]  

  • 7. Should NICE's threshold range for cost per QALY be raised? Yes.
    Towse A
    BMJ; 2009 Jan; 338():b181. PubMed ID: 19171561
    [No Abstract]   [Full Text] [Related]  

  • 8. New agreement on branded drugs for the NHS.
    Naci H; Dixon J
    BMJ; 2019 Jan; 364():l266. PubMed ID: 30658964
    [No Abstract]   [Full Text] [Related]  

  • 9. [Can we decrease pharmacy costs?].
    Azagra Ledesma R
    Aten Primaria; 1993 Feb; 11(3):117-8. PubMed ID: 8453001
    [No Abstract]   [Full Text] [Related]  

  • 10. The Office of Fair Trading report: a prescription for value-based drug pricing.
    Minhas R; Moon JC
    J R Soc Med; 2007 May; 100(5):216-8. PubMed ID: 17470928
    [No Abstract]   [Full Text] [Related]  

  • 11. Therapeutic conservatism.
    McKee M; Foster S; Normand C
    J R Coll Physicians Lond; 1993 Jul; 27(3):338. PubMed ID: 8377175
    [No Abstract]   [Full Text] [Related]  

  • 12. How NICE may be outflanked.
    Ferner RE; McDowell SE
    BMJ; 2006 May; 332(7552):1268-71. PubMed ID: 16735342
    [No Abstract]   [Full Text] [Related]  

  • 13. NICE work: nice try.
    Shuster S
    BMJ; 2006 Jun; 332(7554):1394. PubMed ID: 16763270
    [No Abstract]   [Full Text] [Related]  

  • 14. What to cut.
    Delamothe T
    BMJ; 2009 Apr; 338():b1457. PubMed ID: 19351681
    [No Abstract]   [Full Text] [Related]  

  • 15. International experience of paying for expensive medicines.
    Desai M; Nolte E; Mays N; Nikolentzos A
    BMJ; 2009 May; 338():b1993. PubMed ID: 19482871
    [No Abstract]   [Full Text] [Related]  

  • 16. Can NICE be nicer? In a world of budget constraints there are no easy solutions.
    Drummond M; Sorenson C
    Value Health; 2009; 12(5):634-6. PubMed ID: 19402855
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescribing. The price is right.
    Griffith D; Robinson M
    Health Serv J; 1998 Jul; 108(5613):29. PubMed ID: 10182618
    [No Abstract]   [Full Text] [Related]  

  • 18. New drugs for old: disinvestment and NICE.
    Hughes DA; Ferner RE
    BMJ; 2010 Feb; 340():c572. PubMed ID: 20185495
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative Medicaid drug cost control experiences.
    Kennard LH; Platt WG
    Med Mark Media; 1979 Mar; 14(3):38, 40-3. PubMed ID: 10316799
    [No Abstract]   [Full Text] [Related]  

  • 20. Prescribing. Reverse charges.
    Wilson F
    Health Serv J; 1998 Nov; 108(5630):31. PubMed ID: 10186198
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.